J&J reported $342.91B in Market Capitalization this January of 2025, considering the latest stock price and the number of outstanding shares.

Market Capitalization Change Date
AbbVie USD 348.82B 45.94B Sep/2024
Abbott USD 198.37B 17.6B Sep/2024
Amgen USD 173.13B 5.52B Sep/2024
AstraZeneca GBP 179.65B 11.9B Sep/2024
Baxter International USD 19.37B 2.32B Sep/2024
Bayer EUR 29.79B 3.87B Sep/2024
Becton, Dickinson and Co. USD 69.69B 2.15B Sep/2024
Biogen USD 28.24B 5.52B Sep/2024
Boston Scientific USD 123.41B 10.19B Sep/2024
Bristol-Myers Squibb USD 104.9B 20.71B Sep/2024
CONMED USD 2.22B 77M Sep/2024
Cooper Companies USD 18.58B 850M Jul/2024
Dexcom USD 26.86B 18.23B Sep/2024
Edwards Lifesciences USD 39.75B 15.91B Sep/2024
Eli Lilly USD 842.02B 26.81B Sep/2024
Gilead Sciences USD 104.38B 18.9B Sep/2024
GlaxoSmithKline GBP 62.86B 490.26M Sep/2024
Globus Medical USD 9.69B 437M Sep/2024
Hologic USD 18.92B 1.59B Sep/2024
Insulet USD 16.32B 2.19B Sep/2024
Integra LifeSciences USD 1.41B 890M Sep/2024
Intuitive Surgical USD 174.57B 16.78B Sep/2024
J&J USD 390.12B 38.36B Sep/2024
Merck USD 287.85B 25.71B Sep/2024
Merit Medical Systems USD 5.75B 763M Sep/2024
Novartis CHF 212.75B 16.52B Sep/2024
Pfizer USD 163.99B 5.44B Sep/2024
Regeneron Pharmaceuticals USD 115.88B 73M Sep/2024
Sanofi EUR 128.99B 16.47B Sep/2024
Stryker USD 137.64B 8.02B Sep/2024
Tandem Diabetes Care USD 2.78B 176M Sep/2024
Vertex Pharmaceuticals USD 120.04B 912M Sep/2024
Zimmer Biomet Holdings USD 21.98B 346M Sep/2024
Zoetis USD 88.52B 9.42B Sep/2024